Skip to main content

Table 5 Utility values based on age and risk group and disutility associated with events of IPD and pneumonia

From: Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting

General population utilities

Disutility due to disease

Age

Low risk

At risk

High risk

Bacteraemia

Meningitis

Pneumonia with hospital contact

Pneumonia without hospital contact

18–49 years

0.9564

0.7745

0.7346

-0.13

-0.13

-0.13

-0.004

50–64 years

0.9335

0.7234

0.6852

-0.13

-0.13

-0.13

-0.004

65–74 years

0.9283

0.7308

0.7082

-0.13

-0.13

-0.13

-0.004

75–84 years

0.8921

0.6799

0.6607

-0.13

-0.13

-0.13

-0.004

85–99 years

0.8191

0.6038

0.5643

-0.13

-0.13

-0.13

-0.004

  1. Sources: [39,40,41]